Evidence map›Paper›PMID 39308855›Full record

ReviewFrontiers in immunology2024

Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.

Changling Cao, Li Yuan, Yinfeng Wang, Haitao Liu, Haider Cuello Garcia, Huiqiang Huang, Weiqiang Tan, Yang Zhou, Haifeng Shi, Tingya Jiang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Noninvasive Diagnosis of Kidney Allograft Rejection.Journal of the American Society of Nephrology : JASN · 2025
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Changling Cao *Biostatistics, Research & Development (R&D), AlloDx Biotech (Shanghai), Co., Ltd, Shanghai, China.
Li Yuan *Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yinfeng WangBiostatistics, Research & Development (R&D), AlloDx Biotech (Shanghai), Co., Ltd, Shanghai, China.
Haitao LiuMedical Department, AlloDx Biotech (Shanghai), Co., Ltd, Shanghai, China.
Haider Cuello GarciaSchool of Life Sciences, Jiangsu University, Zhenjiang, China.
Huiqiang HuangBiostatistics, Research & Development (R&D), AlloDx Biotech (Shanghai), Co., Ltd, Shanghai, China.
Weiqiang TanXiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yang ZhouSchool of Life Sciences, Jiangsu University, Zhenjiang, China.
Haifeng ShiSchool of Life Sciences, Jiangsu University, Zhenjiang, China.
Tingya JiangMedical Department, AlloDx Biotech (Shanghai), Co., Ltd, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The donor-derived cell-free DNA (ddcfDNA) is found in the plasma and urine of kidney transplant recipients and displays notable potential in diagnosing rejection, specifically antibody-mediated rejection (ABMR). Nonetheless, the quantitative methods of ddcfDNA lacking standardization and diverse detection techniques can impact the test outcomes. Besides, both the fraction and absolute values of ddcfDNA have been reported as valuable markers for rejection diagnosis, but they carry distinct meanings and are special in various pathological conditions. Additionally, ddcfDNA is highly sensitive to kidney transplant injury. The various sampling times and combination with other diseases can indeed impact ddcfDNA detection values. This review comprehensively analyses the various factors affecting ddcfDNA detection in kidney transplantation, including the number of SNPs and sequencing depths. Furthermore, different pathological conditions, distinct sampling time points, and the presence of complex heterologous signals can influence ddcfDNA testing results in kidney transplantation. The review also provides insights into ddcfDNA testing on different platforms along with key considerations.

Indexed as

Cell-Free Nucleic AcidsGraft RejectionKidney TransplantationTissue DonorsBiomarkersHumansPolymorphism, Single NucleotideBiomarkersCell-Free Nucleic Acidsabsolute and fraction valuedonor derived cfDNAnucleosome foot printingsequencing depthSNP counts

Identifiers

PMID39308855
PMCPMC11412870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.